Evidence mapPaperPMID 8921775Full record

Trial reportCirculation1996

Effect of supplementary antioxidant vitamin intake on carotid arterial wall intima-media thickness in a controlled clinical trial of cholesterol lowering.

S P Azen, D Qian, W J Mack, A Sevanian, R H Selzer, C R Liu, C H Liu, H N Hodis

2 registry-linked trialsAbstract readClinical TrialRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in Circulation, 1996. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It reports registered trial NCT00000599. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
3.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00000599 phase3completed

Cholesterol-Lowering Atherosclerosis Study (CLAS)

Ran1980Registered outcomes0Posted comparisons0ConditionsArterial Occlusive Diseases, Atherosclerosis, Cardiovascular Diseases, Carotid Artery DiseasesArmscolestipol, diet, fat-restricted, niacin
Open the trial in the graph
NCT00005696 completednot on this map

Early Atherosclerosis Change in Two Clinical Trials

TypeobservationalSponsorNational Heart, Lung, and Blood Institute (NHLBI)Ran1994 to 1996ConditionsCardiovascular Diseases, Heart Diseases, Carotid Artery Diseases, Coronary Disease
3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 148 citations in OpenAlex.

  1. Trial
  2. Current Status of Primary, Secondary, and Tertiary Prevention of Coronary Artery Disease.The International journal of angiology : official publication of the International College of Angiology, Inc · 2021
    Review
  3. AGE-RAGE Axis in the Pathophysiology of Chronic Lower Limb Ischemia and a Novel Strategy for Its Treatment.The International journal of angiology : official publication of the International College of Angiology, Inc · 2020
    Review
  4. Article
  5. Article
  6. Review
  7. Pathophysiology and Medical Treatment of Carotid Artery Stenosis.The International journal of angiology : official publication of the International College of Angiology, Inc · 2015
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. [Angiology update].Medizinische Klinik (Munich, Germany : 1983) · 1999
    Review
  16. Review
  17. Article
  18. Oxidative stress in cardiovascular disease.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology
    Review
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

S P AzenStatistical Consultation and Research Center, University of Southern California, Los Angeles 90033, USA.
D Qian
W J Mack
A Sevanian
R H Selzer
C R Liu
C H Liu
H N Hodis
Jet Propulsion Laboratory · US

Funding

VITAMIN E ATHEROSCLEROSIS PREVENTION STUDYR01AG013860 · UNIVERSITY OF SOUTHERN CALIFORNIA · 1996 to 1999
THREE VESSEL RISK FACTOR ANALYSIS COMPLETION OF CLASR01HL045005 · UNIVERSITY OF SOUTHERN CALIFORNIA · 1991 to 1993
EARLY ATHEROSCLEROSIS CHANGE IN TWO CLINICAL TRIALSR01HL049885 · UNIVERSITY OF CALIFORNIA LOS ANGELES · 1994 to 1995
NHLBI NIH HHS R01-HL-45005NHLBI NIH HHS R01-HL-49885NIA NIH HHS R01-AG-13860
6 · The paper itself

Abstract

backgroundThere is accumulating experimental, epidemiological, and clinical evidence of an association between anti-oxidant vitamin intake and reduced risk of coronary heart disease. Using data from the Cholesterol Lowering Atherosclerosis Study (CLAS), we explored the association of self-selected supplementary antioxidant vitamin intake on the rate of progression of early preintrusive atherosclerosis. METHODS AND

resultsCLAS was an arterial imaging trial in which nonsmoking 40- to 59-year-old men with previous coronary artery bypass graft surgery were randomized to colestipol/niacin plus diet or placebo plus diet. The rate of progression of early preintrusive atherosclerosis was determined in 146 subjects using high-resolution B-mode ultrasound quantification of the distal common carotid artery far wall intima-media thickness (IMT). From the nutritional supplement database, 22 subjects had an on-trial average supplementary vitamin E intake of > or = 100 IU per day (high users) and 29 subjects had an average on-trial supplementary vitamin C intake of > or = 250 mg per day (high users). Within the placebo group, less carotid IMT progression was found for high supplementary vitamin E users when compared with low vitamin E users (0.008 versus 0.023 mm/y, P = .03). No effect of vitamin E within the drug group was found. No effect of vitamin C within the drug or placebo group was found.

conclusionsSupplementary vitamin E intake appears to be effective in reducing the progression of atherosclerosis in subjects not treated with lipid-lowering drugs while the process is still confined to the arterial wall (early preintrusive atherosclerosis).

Indexed as

AdultAntioxidantsArteriosclerosisAscorbic AcidCarotid ArteriesCholesterolDisease ProgressionHumansMaleMiddle AgedTunica IntimaTunica MediaUltrasonographyVitamin EAntioxidantsAscorbic AcidCholesterolVitamin E

Identifiers

PMID8921775
OpenAlexW2062485846

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.